Zuellig Pharma Launches Cutting-Edge Clinical Trial Support Center in South Korea

Zuellig Pharma has inaugurated its new Clinical Trial Support Innovation Center in South Korea, aiming to bolster the country's leadership in clinical research innovation. The facility near the Gyeongbu Expressway is 3,800 square meters and emphasizes automation and digitalization, complying with stringent Good Practice standards to support operational efficiency.

Equipped with advanced order fulfillment systems, the center ensures quick and reliable clinical supply delivery. It houses comprehensive temperature-zone support for managing various clinical trial products. Furthermore, its infrastructure caters to controlled environments for specific repackaging needs, maintaining product integrity throughout trials.

The center has managed approximately 13,000 yearly outbound shipments and partnered with major pharmaceutical entities. As of 2025, with South Korea ranking high in global R&D pipelines, the facility is poised to meet increasing demands, enhancing treatment access globally.